Seminars & Events

Tuesday, January 25, 2022, 12:00-13:00
The Neuroscience Program presents
TBD
Speaker: Tabrez J. Siddiqui, PhD
University of Manitoba
Location: ZOOM Meeting - see Poster for LINK

Neuroscience Seminar Series | Hosted by Drs. Steve Ferguson and Max Rousseaux

 

Learning Objectives:

 

TBD.

 

 

 

Friday, January 28, 2022, 12:00-13:00
The Clinical Epidemiology Program presents
Improving end-of-life care in long-term care homes before and during the COVID pandemic
Speaker: Dr. Peter Tanuseputro & Ms. Christina Milani
.
Peter Tanuseputro, MHSc, MD, CCFP, FRCPC
Ottawa Hospital Research Institute, Bruyere Research Institute, University of Ottawa, ICES
&
Christina Milani, BHSc, BA, MSc
Bruyere Research Institute, Ottawa Hospital Research Institute
Location: .
Teams live webinar link:
https://teams.microsoft.com/l/meetup-join/19%3ameeting_Yzc4ZDZiYmQtNjgyNi00MWM1LWFlOGQtY2I2NTIxNzgyZDQ5%40thread.v2/0?context=%7b%22Tid%22%3a%22859b41b6-130f-4d13-a693-1ffec4e7cb5a%22%2c%22Oid%22%3a%221a810a81-b5e5-499a-becc-40efd251c292%22%7d
Abstract:
End-of-life care is essential for long-term care (LTC) residents given their health status and limited life expectancy. In Ontario, 25% of LTC residents die in the first year after admission, with a median survival of 18 months. The COVID-19 pandemic, which has disproportionately affected nursing home residents, has drawn attention to the increased need to address the quality of end-of-life care provided in these settings. Symptom management at the end-of-life (e.g., for pain and dyspnea) is necessary to provide a comfortable death and, we hypothesize, can be used as an indicator for the quality of care provision in LTC. While we have limited data on end-of-life care provision in LTC, data on end-of-life symptom management medications is available through routinely collected health administrative data held at ICES and thus provides an opportunity to explore and evaluate this aspect of end-of-life care quality.

This session will open with a brief review of commonly prescribed end-of-life symptom management medications used in nursing homes. Presenters will describe variations in end-of-life prescribing across Ontario, Canada nursing homes (n=626) before COVID-19 and how prescribing patterns changed after the onset of the pandemic. The session will then transition to a discussion about the challenges and future directions of this work, focusing on implications for policy and practice.
For more information contact: jpeters@ohri.ca (Jodi Peters)
Tuesday, February 01, 2022, 12:00-13:00
The Neuroscience Program presents
TBD
Speaker: Abid Oueslati, PhD
Université Laval
Location: ZOOM Meeting - see Poster for LINK

Neuroscience Seminar Series | Hosted by Drs. Steve Ferguson and Max Rousseaux

 

Learning Objectives:

 

TBD.

 

 

 

Tuesday, February 08, 2022, 12:00-13:00
The Neuroscience Program presents
TBD
Speaker: Katrina Y. Choe, PhD
McMaster University
Location: ZOOM Meeting - see Poster for LINK

Neuroscience Seminar Series | Hosted by Drs. Steve Ferguson and Max Rousseaux

 

Learning Objectives:

 

TBD.

 

 

 

Tuesday, February 15, 2022, 12:00-13:00
The Neuroscience Program presents
TBD
Speaker: Simonetta Sipione, PhD
University of Alberta
Location: ZOOM Meeting - see Poster for LINK

Neuroscience Seminar Series | Hosted by Drs. Steve Ferguson and Max Rousseaux

 

Learning Objectives:

 

TBD.

 

 

 

Tuesday, February 22, 2022, 12:00-13:00
The Neuroscience Program presents
TBD
Speaker: Timothy Murphy, PHD
UBC
Location: ZOOM Meeting - see Poster for LINK

Neuroscience Seminar Series | Hosted by Drs. Steve Ferguson and Max Rousseaux

 

Learning Objectives:

 

TBD.

 

 

 

Please note that OHRI seminars are open to all members of OHRI and partner institutions. Members of the general public are asked to contact the communications office (613-737-8899 x 73325; jganton@ohri.ca) for more information about the research presented at OHRI seminars.